R. Tsudome, “Anti-Oxidative Effect of Dapagliflozin, a Selective Sodium Glucose Transporter-2 Inhibitor, for Cardio-Renal Protection in Patients With Heart Failure With Reduced Ejection Fraction”, Cardiol Res, vol. 16, no. 6, pp. 489–498, Dec. 2025, doi: 10.14740/cr2109.